ACA
NEUTRALM&AArcosa, Inc.
This is the 2026-08-03 snapshot — the signals and analysis for ACA as of this single trading day.
View full ACA research hub →Analysis
Why is ACA exhibiting such steady, low-volatility price action? The stock is currently trading as a merger arbitrage play following the June announcement that CRH will acquire Arcosa in an $8.5 billion all-cash deal at $150 per share. The ALPHA_MALE and PERFECT_STACK technical signals, coupled with a remarkably low 3.4% realized volatility, perfectly illustrate institutional absorption as arbitrageurs lock in the remaining spread. Furthermore, the current RISK_ON macro regime, characterized by exceptionally tight credit spreads and abundant liquidity, provides high conviction that financing and systemic risks will not derail the acquisition. The stock is expected to continue its mechanical grind toward the $150 takeout price as the September shareholder vote approaches.
Fired Signals
Key Takeaways
- Actionable Thesis: ACA is a pure merger arbitrage opportunity, offering a steady, low-volatility grind toward the $150 all-cash buyout price from CRH.
- Key Risk: The primary risk is deal execution, specifically potential antitrust/regulatory hurdles or a failure to secure shareholder approval at the September 4 vote.
- What to Watch: Monitor the August 5 earnings release (which lacks forward guidance due to the pending deal) and the $144.65 support level, as a breach would signal rising deal-break fears.